Koyfin Home > Directory > Health Care > Alexion Pharm Inc > Long-Term Debt / Capital

Alexion Pharm Inc Long-Term Debt / Capital Chart (ALXN)

Alexion Pharm Inc annual/quarterly Long-Term Debt / Capital from 2010 to 2020.
  • Alexion Pharm Inc Long-Term Debt / Capital for the quarter ending June 06, 2020 was $20m a -2.72% decrease of -1m year over year
  • Alexion Pharm Inc Long-Term Debt / Capital for the last 12 months ending June 06, 2020 was $20m a -2.72% decrease of -1m year over year
  • Alexion Pharm Inc Annual Long-Term Debt / Capital for 2019 was $19m a -23.46% decrease of -4m from 2018
  • Alexion Pharm Inc Annual Long-Term Debt / Capital for 2018 was $23m a -8.61% decrease of -2m from 2017
  • Alexion Pharm Inc Annual Long-Term Debt / Capital for 2017 was $25m a -3.18% decrease of -1m from 2016
Other Ratios Metrics:
  • Alexion Pharm Inc Total Debt / Capital for the quarter ending December 12, 2018 was $26m a -0.19% decrease of 0m year over year
  • Alexion Pharm Inc Other Liabilities for the quarter ending December 12, 2018 was $730m a -2.27% decrease of -17m year over year
  • Alexion Pharm Inc Total Debt / Equity for the quarter ending December 12, 2018 was $35m a -0.26% decrease of 0m year over year
View Chart On Koyfin

Quarterly ALXN Long-Term Debt / Capital Data

06/2020$20m
03/2020$18m
12/2019$19m
09/2019$20m
06/2019$21m
03/2019$22m
12/2018$23m
09/2018$23m
06/2018$24m
03/2018$25m

Annual ALXN Long-Term Debt / Capital Data

2019$19m
2018$23m
2017$25m
2016$26m
2015$29m
2014$3m
2013$4m
2012$5m
2010$1m